{"filing":{"accession_number":"0001193125-26-265833","cik":"0001676725","ticker":"IDYA","company_name":"IDEAYA Biosciences, Inc.","form":"8-K","filing_date":"2026-06-10","report_date":null,"primary_document":"d110954d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1676725/000119312526265833/d110954d8k.htm"},"events":[{"id":5651,"run_id":4954,"accession_number":"0001193125-26-265833","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"IDEAYA completed a public offering of 7,222,225 shares of common stock and pre-funded warrants to purchase 5,555,576 additional shares, raising approximately $323.6 million in net proceeds. This is a material dilutive equity issuance disclosed under Item 8.01, representing a substantial increase in shares outstanding and capital raise that would affect a reasonable investor's assessment of ownership dilution and the company's financial position.","company_name":"IDEAYA Biosciences, Inc.","ticker":"IDYA","filing_date":"2026-06-10","form":"8-K","submitted_at":null,"items":[{"id":5844,"accession_number":"0001193125-26-265833","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"IDEAYA completed a public offering of 7,222,225 shares of common stock and pre-funded warrants to purchase 5,555,576 additional shares, raising approximately $323.6 million in net proceeds. This is a material dilutive equity issuance disclosed under Item 8.01, representing a substantial increase in shares outstanding and capital raise that would affect a reasonable investor's assessment of ownership dilution and the company's financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T20:12:08.643900+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5844,"accession_number":"0001193125-26-265833","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"IDEAYA completed a public offering of 7,222,225 shares of common stock and pre-funded warrants to purchase 5,555,576 additional shares, raising approximately $323.6 million in net proceeds. This is a material dilutive equity issuance disclosed under Item 8.01, representing a substantial increase in shares outstanding and capital raise that would affect a reasonable investor's assessment of ownership dilution and the company's financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T20:12:08.643900+00:00","company_name":"IDEAYA Biosciences, Inc.","ticker":"IDYA","filing_date":"2026-06-10"}]}